A population-based validation of the IGCCCG Update Consortium for survival in metastatic non-seminoma testis cancer

CONCLUSIONS: The survival improvement reported by the IGCCCG Update Consortium is also operational in non-seminoma testis cancer patients within the most contemporary SEER database. This observation indicates that the survival improvement is not only applicable to centres of excellence, but also applies to other institutions at large.PMID:38369557 | DOI:10.1093/jjco/hyae011

Source: Clinical Prostate Cancer - February 18, 2024 Category: Cancer & Oncology Authors: Reha-Baris Incesu Simone Morra Lukas Scheipner Francesco Barletta Andrea Baudo Cristina Cano Garcia Stefano Tappero Mattia Luca Piccinelli Zhe Tian Fred Saad Shahrokh F Shariat Ottavio de Cobelli Carlo Terrone Felix K H Chun Luca Carmignani Alberto Brigan Source Type: research